Risk factors of surgical evacuation following second-trimester medical termination of pregnancy

Contraception. 2012 Aug;86(2):141-6. doi: 10.1016/j.contraception.2011.11.070. Epub 2012 Jan 10.

Abstract

Background: Second-trimester medical termination of pregnancy (TOP) is associated with a higher risk of surgical evacuation than earlier medical TOP. Little is known about risk factors of surgical evacuation. Therefore, we assessed these risk factors among women undergoing second-trimester medical TOP.

Study design: Data on 227 women were derived from a prospective randomized trial comparing 1- and 2-day mifepristone-misoprostol intervals in second-trimester medical TOP between 2008 and 2010.

Results: The rate of surgical evacuation was 30.8%. The risk of surgical evacuation was increased by a history of curettage [odds ratio (OR) 4.4; 95% confidence interval (CI) 1.7-11.7], fetal indications for TOP (OR 6.1; 95% CI 1.1-34.4), age above 24 years (OR 2.4; 95% CI 1.1-5.3) and a 2-day interval (OR 2.2; 95% CI 1.1-4.1).

Conclusions: History of curettage, fetal indication, increasing age and 2-day interval between mifepristone and misoprostol increase the risk of surgical evacuation in cases of second-trimester medical TOP. These findings are important when optimizing clinical service in second-trimester TOP.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abortifacient Agents, Nonsteroidal / administration & dosage
  • Abortifacient Agents, Steroidal
  • Abortion, Eugenic / adverse effects*
  • Abortion, Eugenic / methods
  • Abortion, Therapeutic / adverse effects*
  • Abortion, Therapeutic / methods
  • Adolescent
  • Adult
  • Dilatation and Curettage* / adverse effects
  • Dose-Response Relationship, Drug
  • Female
  • Finland / epidemiology
  • Follow-Up Studies
  • Hospitals, University
  • Humans
  • Maternal Age
  • Mifepristone
  • Misoprostol / administration & dosage
  • Placenta, Retained / epidemiology
  • Placenta, Retained / etiology*
  • Placenta, Retained / surgery*
  • Pregnancy
  • Pregnancy Trimester, Second
  • Risk Factors
  • Time Factors
  • Young Adult

Substances

  • Abortifacient Agents, Nonsteroidal
  • Abortifacient Agents, Steroidal
  • Misoprostol
  • Mifepristone

Associated data

  • ISRCTN/ISRCTN09944151